Bruker Total Liabilities 2012-2026 | BRKR
Bruker total liabilities from 2012 to 2026. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Bruker total liabilities for the quarter ending March 31, 2026 were $3.985B, a 7.05% decline year-over-year.
- Bruker total liabilities for 2024 were $4.01B, a 40.43% increase from 2023.
- Bruker total liabilities for 2023 were $2.855B, a 14.85% increase from 2022.
- Bruker total liabilities for 2022 were $2.486B, a 3.09% decline from 2021.
|
Bruker Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $4,010 |
| 2023 | $2,855 |
| 2022 | $2,486 |
| 2021 | $2,565 |
| 2020 | $2,075 |
| 2019 | $1,854 |
| 2018 | $1,224 |
| 2017 | $1,215 |
| 2016 | $1,115 |
| 2015 | $997 |
| 2014 | $1,093 |
| 2013 | $1,138 |
| 2012 | $1,147 |
| 2011 | $1,086 |
|
Bruker Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-09-30 | $3,985 |
| 2025-06-30 | $4,520 |
| 2025-03-31 | $4,100 |
| 2024-12-31 | $4,010 |
| 2024-09-30 | $4,288 |
| 2024-06-30 | $4,096 |
| 2024-03-31 | $3,074 |
| 2023-12-31 | $2,855 |
| 2023-09-30 | $2,593 |
| 2023-06-30 | $2,606 |
| 2023-03-31 | $2,565 |
| 2022-12-31 | $2,486 |
| 2022-09-30 | $2,389 |
| 2022-06-30 | $2,400 |
| 2022-03-31 | $2,519 |
| 2021-12-31 | $2,565 |
| 2021-09-30 | $2,038 |
| 2021-06-30 | $2,072 |
| 2021-03-31 | $2,053 |
| 2020-12-31 | $2,075 |
| 2020-09-30 | $1,917 |
| 2020-06-30 | $2,037 |
| 2020-03-31 | $2,037 |
| 2019-12-31 | $1,854 |
| 2019-09-30 | $1,497 |
| 2019-06-30 | $1,480 |
| 2019-03-31 | $1,321 |
| 2018-12-31 | $1,224 |
| 2018-09-30 | $1,064 |
| 2018-06-30 | $1,021 |
| 2018-03-31 | $1,040 |
| 2017-12-31 | $1,215 |
| 2017-09-30 | $1,222 |
| 2017-06-30 | $1,150 |
| 2017-03-31 | $1,108 |
| 2016-12-31 | $1,115 |
| 2016-09-30 | $1,097 |
| 2016-06-30 | $1,050 |
| 2016-03-31 | $1,031 |
| 2015-12-31 | $997 |
| 2015-09-30 | $1,075 |
| 2015-06-30 | $1,053 |
| 2015-03-31 | $1,051 |
| 2014-12-31 | $1,093 |
| 2014-09-30 | $1,098 |
| 2014-06-30 | $1,119 |
| 2014-03-31 | $1,159 |
| 2013-12-31 | $1,138 |
| 2013-09-30 | $1,156 |
| 2013-06-30 | $1,079 |
| 2013-03-31 | $1,119 |
| 2012-12-31 | $1,147 |
| 2012-09-30 | $1,104 |
| 2012-06-30 | $1,109 |
| 2012-03-31 | $1,135 |
| 2011-12-31 | $1,086 |
| 2011-09-30 | $1,067 |
| 2011-06-30 | $1,069 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $5.722B | $3.437B |
| Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |
| Harvard Bioscience (HBIO) | United States | $0.019B | 0.00 |